Theravance Bio: Q4 Earnings Snapshot

February 23, 2022 GMT

GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Wednesday reported a loss of $32 million in its fourth quarter.

On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of 43 cents.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.

The biopharmaceutical company posted revenue of $14.9 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $15.6 million.

For the year, the company reported a loss of $199.4 million, or $2.87 per share. Revenue was reported as $55.3 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on TBPH at